Cite
HARVARD Citation
Declercq, J. et al. (2022). COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies. Allergy. 77 (1), pp. 304-307. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Declercq, J. et al. (2022). COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies. Allergy. 77 (1), pp. 304-307. [Online].